+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Germ cell tumors (II): VAB II in metastatic testicular cancer



Germ cell tumors (II): VAB II in metastatic testicular cancer



Cancer 42(5): 2162-2168



Between June 1974 and January 1976, 50 patients with metastatic non-seminometous testicular carcinoma were treated with the VAB II protocol. The induction phase consisted of vinblastine (0.4 mg/kg) and actinomycin D (0.02 mg/kg) on day 1. Bleomycin (0.5 mg/kg) was given by continuous infusion for 7 days, and cis-diammine-dichloroplatinum (II) (DDP) (1 mg/kg) was given on day 8. A weekly maintenance of vinblastine and bleomycin, with actinomycin D and DDP on a rotating schedule was given followed by vinblastine, actinomycin D and chlorambucil every 3--4 weeks. Therapy was discontinued after 30--36 months of treatment in the face of continued remission. The response rate was 50% CR, 34% PR with 60% CR and 36% PR in previously untreated patients. Second-look surgery and excision of residual lesions was performed in selected cases. Alopecia, mucositis, nausea, and vomiting were universal. One patient died in the postsurgical period of toxicity from the combination of bleomycin and high concentrations of oxygen. There were seven instances of allergic reactions to DDP. Eleven of 25 complete responders and 4 partial or minor responders who underwent excision of stable disease remain alive from 19 to 35 months following start of therapy, 12 of them without evidence of disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 038942336

Download citation: RISBibTeXText

PMID: 82473

DOI: 10.1002/1097-0142(197811)42:5<2162::aid-cncr2820420512>3.0.co;2-i


Related references

The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Seminars in Oncology 25(2 Suppl 4): 24-32; Discussion 45-8, 1998

Postchemotherapy resections of residual masses from metastatic nonseminomatous testicular germ cell tumors. A Spanish Germ Cell Group study. Journal of Clinical Oncology 23(16_suppl): 4525-4525, 2016

Synchronous bilateral testicular germ cell tumors of different histologic type. Pathogenetic and practical implications of bilaterality in testicular germ cell tumors. Cancer 68(5): 1082-1085, 1991

Embryogenesis and metastatic testicular germ cell tumors of adolescents. Klinische Padiatrie 221(3): 134-135, 2009

N-cadherin expression in primary and metastatic testicular germ cell tumors. Journal of B.U.On. 23(4): 1125-1129, 2018

Back pain a presentation of metastatic testicular germ cell tumors. Lancet 1(8527): 262-264, 1987

Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumors. Journal Of Cancer Research & Clinical Oncology. 119(11): 685-688, 1993

Expression of UTF1 in primary and metastatic testicular germ cell tumors. American Journal of Clinical Pathology 134(4): 604-612, 2010

Epigenetic traits of testicular cancer: from primordial germ cells to germ cell tumors. Epigenomics 6(3): 253-255, 2015

A case of bilateral testicular germ cell tumors of different cell types with maturation in the metastatic region. Hinyokika Kiyo. Acta Urologica Japonica 30(9): 1285-1292, 1984

Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data base. Clinical and Translational Oncology 16(11): 959-965, 2015

Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors. Oncology 55(3): 177-188, 1998

The treatment of metastatic germ cell testicular tumors with bleomycin etoposide and cisplatin. British Journal of Cancer 47(5): 613-620, 1983

Prognostic factors in the treatment of metastatic malignant testicular germ cell tumors. Cancer Immunology Immunotherapy 18(SUPPL): S59, 1984

L-[1-carbon-11]tyrosine imaging of metastatic testicular nonseminoma germ-cell tumors. Journal of Nuclear Medicine 39(6): 1027-1029, 1998